Subscribe to RSS
DOI: 10.1055/s-0029-1208015
© Georg Thieme Verlag KG Stuttgart · New York
EFSUMB Newsletter meets ICUS - The International Contrast Ultrasound Society
Publication History
Publication Date:
27 February 2009 (online)
Members of ICUS Executive Board are pictured just after the organization's launch. Top row: Brian Fowlkes, Fuminori Moriyasu, Maria Cristina Chammas, Stephanie Wilson, Petros Nihoyannopoulos, Michael Main. Bottom Row: Lennard Greenbaum, Paul Grayburn, David Cosgrove, Steven Feinstein, Barry Goldberg. Not pictured: Kurt Jaeger, Shintaro Beppu, Mark Monaghan, Wilson Mathias
New International Contrast Ultrasound Society (ICUS) founding member and Co-President, Dr. Steven Feinstein, interviewed by Professor Michael Bachmann Nielsen December 2008.
Steven Feinstein is a cardiologist specializing in prevention and noninvasive diagnosis of cardiovascular abnormalities. He also serves as director of the echocardiography laboratory at Rush University Medical Center in Chicago. Dr. Feinstein has worked in the contrast-enhanced ultrasound (CEUS) field for approximately 26 years and developed the first two FDA-approved ultrasound contrast agents, Albunex and Optison. He currently coordinates international research teams using CEUS to investigate vessel wall biology and identify early CV disease using surrogate markers of atherosclerosis, including myocardial perfusion, carotid IMT, and neovascularization (intra-plaque and adventitial vasa vasorum).